Literature DB >> 18234692

BART is essential for nuclear retention of STAT3.

Ryuta Muromoto1, Yuichi Sekine, Seiyu Imoto, Osamu Ikeda, Taichiro Okayama, Noriko Sato, Tadashi Matsuda.   

Abstract

Signal transducers and activators of transcription (STATs) mediate cell proliferation, differentiation and survival in immune responses, hematopoiesis, neurogenesis and other biological processes. STAT3, for example, is involved in the epithelial-mesenchymal transition during gastrulation, organogenesis, wound healing and cancer progression. STAT activity is regulated by a variety of mechanisms, including nuclear translocation. To clarify the molecular mechanisms underlying the regulation of STAT activity, we performed yeast two-hybrid screening. Here, we identified binder of ADP-ribosylation factor-like two (BART) as a novel STAT-binding partner. Importantly, we showed that BART is essential for the transcriptional activity and nuclear retention of STAT3. Furthermore, an effector of BART, ADP-ribosylation factor-like 2 (ARL2) was also involved in nuclear retention of STAT3. These results indicate that BART plays an essential role in the nuclear retention of STAT3 through interaction with ARL2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234692     DOI: 10.1093/intimm/dxm154

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  16 in total

1.  ELMO domains, evolutionary and functional characterization of a novel GTPase-activating protein (GAP) domain for Arf protein family GTPases.

Authors:  Michael P East; J Bradford Bowzard; Joel B Dacks; Richard A Kahn
Journal:  J Biol Chem       Date:  2012-09-26       Impact factor: 5.157

2.  BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.

Authors:  Keisuke Taniuchi; Kunihiko Yokotani; Toshiji Saibara
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

3.  A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3.

Authors:  Sumihito Togi; Ryuta Muromoto; Koki Hirashima; Yuichi Kitai; Taichiro Okayama; Osamu Ikeda; Naoki Matsumoto; Shigeyuki Kon; Yuichi Sekine; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2016-04-05       Impact factor: 5.157

Review 4.  Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

Authors:  Bharat B Aggarwal; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Shan R Gupta; Sheeja T Tharakan; Cemile Koca; Sanjit Dey; Bokyung Sung
Journal:  Ann N Y Acad Sci       Date:  2009-08       Impact factor: 5.691

Review 5.  Higher order signaling: ARL2 as regulator of both mitochondrial fusion and microtubule dynamics allows integration of 2 essential cell functions.

Authors:  Joshua W Francis; Rachel E Turn; Laura E Newman; Cara Schiavon; Richard A Kahn
Journal:  Small GTPases       Date:  2016-07-11

6.  HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.

Authors:  Sandeep N Shah; Leslie Cope; Weijie Poh; Amy Belton; Sujayita Roy; C Conover Talbot; Saraswati Sukumar; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

7.  The small GTPase ARL2 is required for cytokinesis in Trypanosoma brucei.

Authors:  Helen P Price; Adam Peltan; Meg Stark; Deborah F Smith
Journal:  Mol Biochem Parasitol       Date:  2010-10       Impact factor: 1.759

Review 8.  STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.

Authors:  Federica Laudisi; Fabio Cherubini; Giovanni Monteleone; Carmine Stolfi
Journal:  Int J Mol Sci       Date:  2018-06-16       Impact factor: 5.923

9.  ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.

Authors:  Yulin Wang; Gefei Guan; Wen Cheng; Yang Jiang; Fengping Shan; Anhua Wu; Peng Cheng; Zongze Guo
Journal:  BMC Cancer       Date:  2018-05-29       Impact factor: 4.430

10.  The ARL2 GTPase is required for mitochondrial morphology, motility, and maintenance of ATP levels.

Authors:  Laura E Newman; Cheng-jing Zhou; Samatha Mudigonda; Alexa L Mattheyses; Eleonora Paradies; Carlo Marya Thomas Marobbio; Richard A Kahn
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.